# FDA Inspection 1268372 - Guilin China Resources Tianhe Pharmaceutical Co., Ltd. - March 28, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/guilin-china-resources-tianhe-pharmaceutical-co-ltd/8e55f59b-b213-4c68-9f30-c9810bec4d5e
Source feed: FDA_Inspections

> FDA Inspection 1268372 for Guilin China Resources Tianhe Pharmaceutical Co., Ltd. on March 28, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268372
- Company Name: Guilin China Resources Tianhe Pharmaceutical Co., Ltd.
- Inspection Date: 2025-03-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1268372 - 2025-03-28](https://www.globalkeysolutions.net/records/fda_inspections/guilin-china-resources-tianhe-pharmaceutical-co-ltd/36ca8a03-829f-4995-890a-d40a2cdcfabf)
- [FDA Inspection 1078047 - 2019-01-11](https://www.globalkeysolutions.net/records/fda_inspections/guilin-china-resources-tianhe-pharmaceutical-co-ltd/497581b2-9e0b-4df5-9e17-370621d1acb6)

Company: https://www.globalkeysolutions.net/companies/guilin-china-resources-tianhe-pharmaceutical-co-ltd/a267013f-a39d-4270-a42a-8ba4706e6b86

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c